is the generic ingredient in one branded drug marketed by Astrazeneca Ab
and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.
This ingredient has one hundred and eighteen patent family members
in twenty-five countries.
There are two drug master file entries
for pramlintide acetate. Two suppliers
are listed for this compound.